| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/13/2004 | EP0921821B1 2-methoxyestradiol-induced apoptosis in cancer cells |
| 10/13/2004 | EP0902664A4 Synchronising of animal oestrus and intra vaginal devices useful therein |
| 10/13/2004 | EP0873136B1 High fluorescence specific immune enhancing factor and methods of use for same |
| 10/13/2004 | EP0848712B1 Dihydropyran derivatives as viral neuraminidase inhibitors |
| 10/13/2004 | EP0840616B1 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases |
| 10/13/2004 | EP0839155B1 CYSTEINE PROTEASE INHIBITORS FOR USE IN TREATMENT OF IgE MEDIATED ALLERGIC DISEASES |
| 10/13/2004 | EP0812588B1 Pharmaceutical external preparations for topical administration comprising 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol for the treatment of diseases induced from immune disorder |
| 10/13/2004 | EP0802912B1 Piperidine derivatives having tachykinin antagonist activity |
| 10/13/2004 | EP0736036B1 Kininogen inhibitors |
| 10/13/2004 | EP0719147B1 Gene therapy for solid tumors, papillomas and warts |
| 10/13/2004 | EP0595838B1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 10/13/2004 | EP0542988B1 Improved euthanasia compositions |
| 10/13/2004 | CN1537167A Von willebrand factor (VWF)-cleaving enzyme |
| 10/13/2004 | CN1537115A C2,5'-disubstituted and N6, C2, 5' trisubstituted adenosine derivatives and their different uses |
| 10/13/2004 | CN1537113A Process for production of N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide (zaleplom) |
| 10/13/2004 | CN1537112A Pyrimidine compound |
| 10/13/2004 | CN1537111A Urea substituted imidazoquinolines |
| 10/13/2004 | CN1537105A Quinazolines as MMP-13 inhibitors |
| 10/13/2004 | CN1537104A Pyrimidine derivatives useful as selective COX-2 inhibitors |
| 10/13/2004 | CN1537103A Kinetic resolution of intermediater body for preparing benazepril and its analogues |
| 10/13/2004 | CN1537102A Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 10/13/2004 | CN1537101A Pyridine matrix metalloproteinase inhibitors |
| 10/13/2004 | CN1537100A Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
| 10/13/2004 | CN1537098A Crystalline forms VI and VII of atorvastatin calcium |
| 10/13/2004 | CN1537094A Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities |
| 10/13/2004 | CN1537093A Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 10/13/2004 | CN1537025A 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1.1-dioxo-1 lambda b-thiomorpholin-4-yl)-4-(methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-N-methyl-isobutyramide |
| 10/13/2004 | CN1537019A Medical combination of aldosterone receptor antagonist and HMG CoA reductase inhibitor |
| 10/13/2004 | CN1537018A Therapeutic compositions for repairing chondropathy |
| 10/13/2004 | CN1537017A Remedie for inflammatory bowel diseases |
| 10/13/2004 | CN1537016A Remedies for psychoneurosis |
| 10/13/2004 | CN1537011A Composition for prevention and treatment of influenza having antivirus effect |
| 10/13/2004 | CN1537010A Drugs for ameliorating postcibal hyperglycaemia |
| 10/13/2004 | CN1537009A Method for treating or preventing functional vitamin B12 dificiency in individual and to medical compositions for use in said method |
| 10/13/2004 | CN1537008A Pharmaceutical combination comprising either (S)-20ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl}ethoxy)phenyl] propanoic acid |
| 10/13/2004 | CN1537007A 2 methyl-thieno-benzodiazepine lyophilizde formulation |
| 10/13/2004 | CN1537006A Drug combination for treatment of headache comprising mirtazapine and paracetamol or non-steroidal anti-inflammatory drug |
| 10/13/2004 | CN1537005A Amorphous cefditoren pivoxil composition and process for producing the same |
| 10/13/2004 | CN1537004A Compositions containing imidazotriazinone for nasal application |
| 10/13/2004 | CN1537003A Pharmaceutical composition comprising tricyclic compound for prevention or treatment of skin diseases |
| 10/13/2004 | CN1537002A Novel theterocyclic analogs of diphenylethylene compounds |
| 10/13/2004 | CN1537001A Malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 10/13/2004 | CN1537000A Novel imidazolidine derivatives, their preparation and their use as VLA-4 antagonists |
| 10/13/2004 | CN1536999A Crystalline forms |
| 10/13/2004 | CN1536998A Integrin inhibitors for treatment of eye diseases |
| 10/13/2004 | CN1536997A Crystalline composition containing escitalopram |
| 10/13/2004 | CN1536996A (-)-olivil as antioxidant |
| 10/13/2004 | CN1536995A Antitumor compositions containing taxane derivatives |
| 10/13/2004 | CN1536994A Hypoglycemic agent |
| 10/13/2004 | CN1536993A Solid pharmaceutical composition comprising 4-cyano-trifluoro-N-[3-(40fluorophenylsulphonyl)2-hydroxy-2-methylpropiono]-m-toluidide and PVP |
| 10/13/2004 | CN1536992A Carbamates of 2-heterocyclic-1, 2-ethanediols |
| 10/13/2004 | CN1536991A (f)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 10/13/2004 | CN1536990A Pharmaceutical composition comprising (-)-secoisolariciresinol |
| 10/13/2004 | CN1536989A Oral compositions comprising host-respones modulating agent for promoting whole body health |
| 10/13/2004 | CN1536988A Sustained-release delivery system |
| 10/13/2004 | CN1536987A Sustained-release suspension of ceftiofur hydrochloride |
| 10/13/2004 | CN1536986A Intravaginal drug delivery devices for administration of antimicrobial agent |
| 10/13/2004 | CN1535981A Peptide capable of lyzing pathogen and its application |
| 10/13/2004 | CN1535978A Circular muscle glycoside diphosphoethoxymethyl ribose compound |
| 10/13/2004 | CN1535974A Method for producing glucolipid substance using ganglioside as main component |
| 10/13/2004 | CN1535972A New compound,its preparation method, medicine preparation using said compound as active component, its action and application |
| 10/13/2004 | CN1535971A Fermentation preparation method of cell inhibitor and its crystal form |
| 10/13/2004 | CN1535969A Total alkaloid of xiatianwu (a Chinese medicinal material), its preparation method and application |
| 10/13/2004 | CN1535968A Tetrahydro pyridyl or pyridyl heterocycle derivative |
| 10/13/2004 | CN1535958A Alpha-substituted pyrimidine. thioalkyl and alkyl ether compound |
| 10/13/2004 | CN1535957A New isoquinoline compounds, their preparation method and medicine composition contaning them |
| 10/13/2004 | CN1535718A Houpo Huanglian Ye (magnolia coptis liguor) |
| 10/13/2004 | CN1535713A Yixintong dripping pill and its preparation method |
| 10/13/2004 | CN1535712A New anticancer medicine |
| 10/13/2004 | CN1535709A Capsicum ethylsine tablet preparation and its preparation method |
| 10/13/2004 | CN1535692A Nitrogen oxide for curing inplammation |
| 10/13/2004 | CN1535691A Helicid powder injection preparation and its preparation method |
| 10/13/2004 | CN1535690A Helicid soft capsule and its preparation method |
| 10/13/2004 | CN1535689A Medicine composition for curing tumor |
| 10/13/2004 | CN1535688A Combined preparation containing morpholine anthracene nucleus compound and autcancer preparation |
| 10/13/2004 | CN1535687A Antipruritic |
| 10/13/2004 | CN1535686A Slowly-released preparation containing loratadine and pseudoephedrine sulfate and its preparation method |
| 10/13/2004 | CN1535685A Adhesive plaster for curing neurodermatitis |
| 10/13/2004 | CN1535684A Aconitum kusnezoffii methylsine powder injection preparation and its preparation method |
| 10/13/2004 | CN1535683A Aconitum kusnezoffii methylsine aerosol and its preparation method |
| 10/13/2004 | CN1535682A Medicine for improved bladder excretion capacity |
| 10/13/2004 | CN1535681A Application of dipeptide base peptidase IV effector for reducing blood sugar level of mammal |
| 10/13/2004 | CN1535680A Abidor inclusion compound |
| 10/13/2004 | CN1535679A Medicine composition containing taxol substance and its preparation method |
| 10/13/2004 | CN1535678A Stable acetylglutamine freeze-dried powder injection preparation and preparation process |
| 10/13/2004 | CN1535605A Drink and food |
| 10/13/2004 | CN1535581A Composition for killing microbe |
| 10/13/2004 | CN1170928C Liver cancer related gene and its application |
| 10/13/2004 | CN1170849C Connective tissue growth factor fragments and methods and uses thereof |
| 10/13/2004 | CN1170842C New amidinobenzylamine derivatives and their use as thrombin inhibitors |
| 10/13/2004 | CN1170831C New process for preparation of vinyl-pyrrolidinone cephalosporine derivatives |
| 10/13/2004 | CN1170829C Optically active pyrrolopyridazine compound |
| 10/13/2004 | CN1170827C Benzofurylpyrone deriuvatives |
| 10/13/2004 | CN1170826C Amide compounds |
| 10/13/2004 | CN1170822C Imidazole compounds and medicinal use thereof |
| 10/13/2004 | CN1170819C Piperidine alcohols |
| 10/13/2004 | CN1170814C Amide compounds for potentiation of cholinergic activity |
| 10/13/2004 | CN1170811C Branched chain amino acid-dependent aminotransferase inhibitors and their use in treatment of diabetic retinopathy |
| 10/13/2004 | CN1170584C Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives |
| 10/13/2004 | CN1170578C Medicine composition for improving memory and intelligence |